HIV infection has transitioned from an acute, fatal disease to a chronic one managed by
antiretroviral therapy. Thus, the aging population of people living with HIV (PLWH) continues …

The recent literature contains reports of thrombotic episodes occurring in patients with
human immunodeficiency virus (HIV) infection and various abnormalities predisposing to a …

HIV infection has been recognized as a prothrombotic condition and this association has
now been proven by a large number of studies with a reported VTE frequency among HIV …

Infection with the human immunodeficiency virus (HIV) is still a major health problem world-
wide. HIV infection has changed into a chronic infection with the chance of developing long …

Human immunodeficiency virus infection is an illness with protean manifestations including
hematological abnormalities. Thromboembolic complications in HIV-infected patients have …

The array of clinicopathologic factors associated with acquired immune deficiency syndrome
(AIDS) patients continues to increase and surprise many physicians. The recent literature …

Venous thrombotic events (VTEs) may occur at higher rates among patients with HIV; some
studies suggest that highly active antiretroviral therapy (HAART) may increase the risk for …

Objective The association between HIV infection and the risk of venous thromboembolism
(VTE) is controversial. We examined the risk of VTE in HIV‐infected individuals compared …

Background. Recent reports suggest that patients infected with human immunodeficiency
virus (HIV) may have an increased risk of developing thrombosis, but the etiology, risk …

Highly active antiretroviral therapy (HAART) has greatly reduced the risk of early death from
opportunistic infections and extended the lifespan of people infected with the human …